CLINICAL_TRIALS
trial_result
· 2014-02-26
Clinical Trial Update: Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis [Phase 3]
Summary
A Phase 3 randomized, placebo-controlled trial of Denosumab in Japanese patients with osteoporosis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2014-02-26